Opportunity ID: 317675

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-19-055
Funding Opportunity Title: Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.353 — 21st Century Cures Act – Beau Biden Cancer Moonshot
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 28, 2019
Last Updated Date: Jun 28, 2019
Original Closing Date for Applications: Aug 30, 2019
Current Closing Date for Applications: Aug 30, 2019
Archive Date: Oct 05, 2019
Estimated Total Program Funding:
Award Ceiling: $700,000
Award Floor:

Eligibility

Eligible Applicants: City or township governments
For profit organizations other than small businesses
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Private institutions of higher education
Small businesses
Public housing authorities/Indian housing authorities
State governments
Independent school districts
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will support the development of technology, tools that will facilitate, accelerate, and/or enhance research using advanced human-derived next generation cancer models, such as organoids, conditionally reprogrammed cells, and others. The studies proposed under this FOA must focus entirely on the next generation cancer models developed under the auspices of an international consortium with NCI participation, Human Cancer Models Initiative. “Technology tools” to be developed under this FOA may include new and/or optimized laboratory methods, reagents/reference materials, agents for NGCMs perturbation or screening read-outs, and/or software/bioinformatics tools for data processing and/or facilitated/enhanced interpretations. (The development of new hardware/equipment will not be supported). The proposed technology tools are expected to a) facilitate the utilization of the cancer models, e.g., in terms of increasing robustness, rigor, and/or reproducibility, b) enable advanced interpretations of experiments in which these model are used, c) design and test CRISPR reagents for all cancer and NGCM types, and d) develop robust approaches to method standardization, quality assurance/control, etc., that could serve as routine workflows/best practices for use in wide range of laboratories. The collective outcomes of projects under this FOA should facilitate the adoption of NGCMs by the research community and expedite sharing and validating of NGCMs-derived results. The new tools and broader use of NCGMs are expected to contribute to the progress in such areas as the identification of novel therapeutic targets, mechanisms of resistance, development of diagnostic and/or predictive biomarkers, and other aspects relevant to precision oncology. This FOA is associated with the Beau Biden Cancer Moonshot SM Initiative that is intended to accelerate cancer research. Specifically, this F
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-055.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00252464 Jul 30, 2019 Aug 30, 2019 View

Package 1

Mandatory forms

317675 RR_SF424_2_0-2.0.pdf

317675 PHS398_CoverPageSupplement_4_0-4.0.pdf

317675 RR_OtherProjectInfo_1_4-1.4.pdf

317675 PerformanceSite_2_0-2.0.pdf

317675 RR_KeyPersonExpanded_2_0-2.0.pdf

317675 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

317675 RR_Budget_1_4-1.4.pdf

317675 RR_SubawardBudget30_1_4-1.4.pdf

317675 PHS398_ModularBudget_1_2-1.2.pdf

317675 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T19:39:01-05:00

Share This Post, Choose Your Platform!

About the Author: